Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 154, Issue 2, 2011, Pages 141-145

  Vitoratos, Nikolaos ^a   Lambrinoudaki, Irene ^a   Rizos, Demetrios ^a   Armeni, Eleni ^a   Alexandrou, Andreas ^b   Creatsas, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bone turnover; Osteoprotegerin; Pre eclampsia; RANKL

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GREECE; HUMAN; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PUERPERIUM;

EID: 79951514010     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2010.10.009     Document Type: Article

References (37)

1. R.M. Pitkin Calcium metabolism in pregnancy and the perinatal period: a review Am J Obstet Gynecol 151 1985 99 109 (Pubitemid 15236326)
2. W. Khovidhunkit, and S. Epstein Osteoporosis in pregnancy Osteoporos Int 6 5 1996 345 354 (Pubitemid 26355892)
3. K.A. Ward, J.E. Adams, and M.Z. Mughal Bone status during adolescence, pregnancy and lactation Curr Opin Obstet Gynecol 17 2005 435 439 (Pubitemid 41044416)
4. G.D. Roodman Cell biology of the osteoclast Exp Hematol 27 1999 1229 1241 (Pubitemid 29347472)
5. W.S. Simonet, D.L. Lacey, and C.R. Dunstan Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319 (Pubitemid 27199902)
6. H. Yasuda, N. Shima, and N. Nakagawa Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endocrinology 139 1998 1329 1337 (Pubitemid 28510154)
7. A. Leibbrandt, and J.M. Penninger RANK/RANKL: regulators of immune responses and bone physiology Ann NY Acad Sci 1143 2008 123 150
8. M.C. Walsh, and Y. Choi Biology of the TRANCE axis Cytokine Growth Factor Rev 14 2003 251 263 (Pubitemid 36693145)
9. M. Shaarawy, S. Zaki, A.M. Ramzi, M.E. Salem, and A.M. El-Minawi Feto-maternal bone remodeling in normal pregnancy and preeclampsia J Soc Gynecol Investig 12 2005 343 348 (Pubitemid 40848458)
10. N. Anim-Nyame, S.R. Sooranna, J. Jones, J. Alaghband-Zadeh, P.J. Steer, and M.R. Johnson Biochemical markers of maternal bone turnover are elevated in pre-eclampsia BJOG 108 2001 258 262 (Pubitemid 32210124)
11. Y. Kumtepe, H. Aksoy, and M. Ingec Bone turnover in preeclamptic and normotensive pregnancy Int J Gynaecol Obstet 88 3 2005 323 324 (Pubitemid 40283613)
12. N. Anim-Nyame, S.R. Sooranna, J. Jones, J. Alaghband-Zadeh, P.J. Steer, and M.R. Johnson A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia BJOG: An Int J Obstet Gynaecol 109 June 2002 708 713 (Pubitemid 37329285)
13. H. Uemura, T. Yasui, and M. Kiyokawa Serum osteoprotegerin/ osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers J Endocrinol 174 2002 353 359 (Pubitemid 34965775)
14. J.S. Hong, J. Santolaya-Forgas, and R. Romero Maternal plasma osteoprotegerin concentration in normal pregnancy Am J Obstet Gynecol 193 2005 1011 1015 (Pubitemid 41285486)
15. B. Sibai, G. Dekker, and M. Kupferminc Pre-eclampsia Lancet 365 2005 785 799
16. J.M. Roberts, and K.Y. Lain Recent insights into the pathogenesis of pre-eclampsia Placenta 23 2002 359 372 (Pubitemid 41110499)
17. Report of the national high blood pressure education program working group on high blood pressure in pregnancy Am J Obstet Gynecol 183 2000 S1 S22
18. E. Helewa Michael, F. Burrows Robert, S. John, W. Keith, B. Philippa, and W. Rabkin Simon Report of the Canadian hypertension Society consensus conference. 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy Can Med Assoc J 157 6 1997 715 725
19. L. Leeman, and P. Fontaine Hypertensive disorders of pregnancy Am Fam Physician 78 1 2008 93 100
20. P. Reid, and I. Holen Pathophysiological roles of osteoprotegerin (OPG) Eur J Cell Biol 88 2009 1 17
21. M. Schoppet, K.T. Preissner, and L.C. Hofbauer RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function Arterioscler Thromb Vasc Biol 22 2002 549 553 (Pubitemid 34408732)
22. U.M. Malyankar, M. Scatena, K.L. Suchland, T.J. Yun, E.A. Clark, and C.M. Giachelli Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells J Biol Chem 275 2000 20959 20962 (Pubitemid 30481782)
23. S. Kiechl, G. Schett, and G. Wenning Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease Circulation 109 2004 2175 2180 (Pubitemid 38625393)
24. A. Van Campenhout, and J. Golledge Osteoprotegerin, vascular calcification and atherosclerosis Atherosclerosis 204 2009 321 329
25. D. Pearson, M. Kaur, P. San, N. Lawson, P. Baker, and D. Hosking Recovery of pregnancy mediated bone loss during lactation Bone 34 2004 570 578 (Pubitemid 38314922)
26. A.J. Black, J. Topping, B. Durham, R.G. Farquharson, and W.D. Fraser A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy J Bone Miner Res 15 2000 557 563 (Pubitemid 30134101)
27. L. Hellmeyer, V. Ziller, G. Anderer, A. Ossendorf, S. Schmidt, and P. Hadji Biochemical markers of bone turnover during pregnancy: a longitudinal study Exp Clin Endocrinol Diabetes 114 9 2006 506 510 (Pubitemid 44870899)
28. M. Gorzelak, D. Darmochwal-Kolarz, and M. Jablonski The concentrations of osteocalcin and degradation products of type I collagen in pregnant women with pre-eclampsia Eur J Obstet Gynecol Reprod Biol 98 2001 23 27 (Pubitemid 32758830)
29. K.E. Naylor, A. Rogers, R.B. Fraser, V. Hall, R. Eastell, and A. Blumsohn Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation J Clin Endocrinol Metab 88 11 2003 5361 5365 (Pubitemid 37452739)
30. L. Ardeshirpour, P. Dann, and D.J. Adams Weaning triggers a decrease in receptor activator of nuclear factor-kappaB ligand expression, widespread osteoclast apoptosis, and rapid recovery of bone mass after lactation in mice Endocrinology 148 8 2007 3875 3886 (Pubitemid 47105861)
31. E. Laresgoiti-Servitje, N. Gómez-López, and D.M. Olson An immunological insight into the origins of pre-eclampsia Hum Reprod Update 16 5 2010 510 524
32. S. Saito, A. Shiozaki, A. Nakashima, M. Sakai, and Y. Sasaki The role of the immune system in preeclampsia Mol Aspects Med 28 2 2007 192 209 (Pubitemid 46843191)
33. T. Kaji, T. Yasui, and M. Suto Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women Bone 40 2007 1088 1094 (Pubitemid 46386556)
34. J.W. Hung, M.Y. Tsai, B.Y. Yang, and J.F. Chen Maternal osteoporosis after prolonged magnesium sulfate tocolysis therapy: a case report Arch Phys Med Rehabil 86 1 2005 146 149
35. A.L. Levav, L. Chan, and R.J. Wapner Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report Am J Perinatol 15 1 1998 43 46 (Pubitemid 28072977)
36. B. Xu, A. Makris, C. Thornton, R. Ogle, J.S. Horvath, and A. Hennessy Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy J Hypertens 24 5 2006 915 922 (Pubitemid 43670463)
37. B. Xu, C. Thornton, A. Makris, R. Ogle, and A. Hennessy Anti-hypertensive drugs alter cytokine production from preeclamptic placentas and peripheral blood mononuclear cells Hypertens Pregnancy 26 3 2007 343 356 (Pubitemid 47295358)